Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camelia Quek

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2019
Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical TrialsJarem Edwards, Annie Tasker, Inês Pires da Silva, et al.
Cancers|July 2, 2021
Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/- Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic TargetsTuba N Gide, Inês Pires da Silva, Camelia Quek, et al.
Diagnostics (Basel, Switzerland)|January 11, 2025
<i>Naegleria fowleri:</i> Portrait of a Cerebral KillerNguyen The Nguyen Phung, Huong Thien Pham, Thuc Thanh Tran, et al.
Nature Communications|April 8, 2024
Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanomaXinyu Bai, Grace H Attrill, Tuba N Gide, et al.
Viruses|February 27, 2026
Unmasking Viral Causes of Hospitalized Respiratory Infection: Five Years of Respiratory Virus Surveillance in Vietnam by Multiplex Real-Time PCR AssayHuong T Pham, Van H Pham, Duy K Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2018
CD103<sup>+</sup> Tumor-Resident CD8<sup>+</sup> T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 TreatmentJarem Edwards, James S Wilmott, Jason Madore, et al.
JCI Insight|September 29, 2022
Distinct pretreatment innate immune landscape and posttreatment T cell responses underlie immunotherapy-induced colitisKazi J Nahar, Felix Marsh-Wakefield, Robert V Rawson, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Tissue-wide profiling of human lungs reveals spatial sequestration of macrophages in tuberculosisWei Xiao, Andrew J Sawyer, Siwei Mo, et al.
Journal of Translational Medicine|April 13, 2023
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approachYizhe Mao, Tuba N Gide, Nurudeen A Adegoke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2019
Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K <i>BRAF</i>-Mutant MelanomaInês Pires da Silva, Kevin Y X Wang, James S Wilmott, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2019
Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical TrialsJarem Edwards, Annie Tasker, Inês Pires da Silva, et al.
Cancers|July 2, 2021
Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/- Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic TargetsTuba N Gide, Inês Pires da Silva, Camelia Quek, et al.
Diagnostics (Basel, Switzerland)|January 11, 2025
<i>Naegleria fowleri:</i> Portrait of a Cerebral KillerNguyen The Nguyen Phung, Huong Thien Pham, Thuc Thanh Tran, et al.
Nature Communications|April 8, 2024
Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanomaXinyu Bai, Grace H Attrill, Tuba N Gide, et al.
Viruses|February 27, 2026
Unmasking Viral Causes of Hospitalized Respiratory Infection: Five Years of Respiratory Virus Surveillance in Vietnam by Multiplex Real-Time PCR AssayHuong T Pham, Van H Pham, Duy K Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2018
CD103<sup>+</sup> Tumor-Resident CD8<sup>+</sup> T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 TreatmentJarem Edwards, James S Wilmott, Jason Madore, et al.
JCI Insight|September 29, 2022
Distinct pretreatment innate immune landscape and posttreatment T cell responses underlie immunotherapy-induced colitisKazi J Nahar, Felix Marsh-Wakefield, Robert V Rawson, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Tissue-wide profiling of human lungs reveals spatial sequestration of macrophages in tuberculosisWei Xiao, Andrew J Sawyer, Siwei Mo, et al.
Journal of Translational Medicine|April 13, 2023
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approachYizhe Mao, Tuba N Gide, Nurudeen A Adegoke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2019
Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K <i>BRAF</i>-Mutant MelanomaInês Pires da Silva, Kevin Y X Wang, James S Wilmott, et al.
Pageof 5